Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B
about
A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitroIn vitro anti-Herpes simplex virus activity of crude extract of the roots of Nauclea latifolia Smith (Rubiaceae).Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approachPeptides Derived from Glycoproteins H and B of Herpes Simplex Virus Type 1 and Herpes Simplex Virus Type 2 Are Capable of Blocking Herpetic Infection in vitro.Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeuticsNovel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread.Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus.Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood.Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism.In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections
P2860
Q34309568-C94B3854-E669-42BF-9F8B-411A00702EABQ35019283-94539596-84ED-45CD-833F-CE6A30F6ACABQ36176682-3D3A451B-A887-46CC-B711-4C424EBB323DQ36318677-22F4F9A1-758C-4285-AA1D-89FAC2721ED9Q36866689-051205FF-172E-4F6E-88EE-A661F6B8D267Q39244734-6C9F206B-5EFE-4881-8236-84380B25AEE7Q39541397-888E4E18-91A9-4E52-A5A4-52E31D59C3CEQ39666949-4771A4A1-961B-45A8-BB75-6280A107CF2EQ40027571-4628FB8D-7E1E-4A89-A712-D617B58AB46AQ40334600-F33754B4-0778-470A-AE3F-442C5B5ABDBDQ42015623-A32CD0A7-4538-45C1-95A6-F184BAA2A1C6Q42207445-7CFEFDCE-6E96-4CA0-860F-6DEC3E2CB0BBQ45392613-9D694AA3-708D-4A23-993E-1BE225EC969FQ47564328-D7AA072C-E61C-44B9-B75E-53113F0BCAB9Q56789970-FD2EDB37-E4F5-4DCC-A8D8-4A97F45BE229
P2860
Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@en
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@nl
type
label
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@en
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@nl
prefLabel
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@en
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@nl
P2093
P2860
P1433
P1476
Virucidal activity of a GT-ric ...... rus mediated by glycoprotein B
@en
P2093
Benjamin Shogan
Donald M Coen
Gilbert B Mulamba
Lori Kruse
P2860
P304
P356
10.1128/JVI.80.10.4740-4747.2006
P407
P577
2006-05-01T00:00:00Z